Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | PG-E2 as biomarker for MSC transfer response

Francesco Dazzi • 15 Jun 2019
EHA 2019
General

Francesco Dazzi, MD, PhD, King’s College London, London, UK, explains that the presence of PG-E2 can act as a biomarker for response to mesenchymal stromal cell (MSC) transfer. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Francesco Dazzi

3:35
Challenges with implementing mesenchymal stem cells into practice
Francesco Dazzi • 4 Sep 2020
1:55
Mesenchymal stromal cells in 2020
Francesco Dazzi • 3 Sep 2020
2:07
Cell death pathways in MSC
Francesco Dazzi • 14 Jun 2019
1:18
Mesenchymal stromal cells: a mechanistic overview
Francesco Dazzi • 15 Jun 2019

Related Videos

1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals